We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada’s Guidance on Cell Therapy Studies Focuses on Risks, Delivery
Canada’s Guidance on Cell Therapy Studies Focuses on Risks, Delivery
November 11, 2014
Health Canada wants sponsors of cell therapy products to conduct preclinical studies either in vitro or in animals to address potential risks and delivery issues before initiating human trials of the products.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor